Singular Health Group Ltd ( (AU:SHG) ) has shared an update.
Singular Health Group Ltd announced that all resolutions at their recent General Meeting were carried via a poll. This includes the ratification of placement shares and the issuance of options to directors, which reflects strong shareholder support and could enhance the company’s strategic initiatives and market positioning.
More about Singular Health Group Ltd
Singular Health is a Western Australian, ASX-listed medical technology company focused on creating an integrated healthcare ecosystem. Its primary product, the 3Dicom software, empowers patients and practitioners to better visualize and understand medical imaging data, with the 3Dicom MD® cleared for diagnostic use in the United States.
YTD Price Performance: 4.55%
Average Trading Volume: 866,430
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$59.85M
See more data about SHG stock on TipRanks’ Stock Analysis page.